| Review of triazine antiprotozoal drugs used in veterinary medicine |
15 |
| Mathematical modeling and simulation in animal health. Part III: Using nonlinear mixed-effects to characterize and quantify variability in drug pharmacokinetics |
11 |
| Amoxicillin-current use in swine medicine |
10 |
| Tilmicosin enteric granules and premix to pigs: Antimicrobial susceptibility testing and comparative pharmacokinetics |
6 |
| Pharmacokinetics of florfenicol and its metabolite florfenicol amine in crucian carp (Carassius auratus) at three temperatures after one single intramuscular injection |
6 |
| Repurposing Ionophores as novel antimicrobial agents for the treatment of bovine mastitis caused by Gram-positive pathogens |
5 |
| Pharmacokinetics of ceftriaxone in Green sea turtles (Chelonia mydas) following intravenous and intramuscular administration at two dosages |
5 |
| Is there a place for dexmedetomidine in equine anaesthesia and analgesia? A systematic review (2005-2017) |
5 |
| An integrated experimental and physiologically based pharmacokinetic modeling study of penicillin G in heavy sows |
5 |
| Drug residues in poultry meat: A literature review of commonly used veterinary antibacterials and anthelmintics used in poultry |
5 |
| Pharmacokinetics of levofloxacin after single intravenous, oral and subcutaneous administration to dogs |
5 |
| Use of praziquantel to control platyhelminth parasites of fish |
5 |
| Pharmacokinetics and bioavailability of tolfenamic acid in sheep |
5 |
| Pharmacokinetics of sanguinarine, chelerythrine, and their metabolites in broiler chickens following oral and intravenous administration |
4 |
| PK/PD modeling of flunixin meglumine in a kaolin-induced inflammation model in piglets |
4 |
| Pharmacokinetic profile of Ceftiofur Hydrochloride Injection in lactating Holstein dairy cows |
4 |
| Pharmacokinetics and pharmacodynamics of intravenous and transdermal flunixin meglumine in meat goats |
4 |
| Pharmacokinetics of florfenicol in blunt-snout bream (Megalobrama amblycephala) at two water temperatures with single-dose oral administration |
4 |
| Amelioration of oxidative stress using N-acetylcysteine in canine parvoviral enteritis |
4 |
| Clinical pharmacokinetics of a dexmedetomidine-methadone combination in dogs undergoing routine anaesthesia after buccal or intramuscular administration |
4 |
| Evaluation of pharmacokinetic properties of vitacoxib in fasted and fed horses |
3 |
| Nonlinear mixed-effects pharmacokinetic modeling of the novel COX-2 selective inhibitor vitacoxib in dogs |
3 |
| Pharmacokinetics of fentanyl citrate and norfentanyl in Holstein calves and effect of analytical performances on fentanyl parameter estimation |
3 |
| Integration of pharmacokinetic-pharmacodynamic for dose optimization of doxycycline against Haemophilus parasuis in pigs |
3 |
| Pharmacokinetic profiles of florfenicol in spotted halibut, Verasper variegatus, at two water temperatures |
3 |
| Pharmacokinetics of cefquinome after single and repeated subcutaneous administrations in sheep |
3 |
| Pharmacokinetics and antinociceptive effects of the soluble epoxide hydrolase inhibitor t-TUCB in horses with experimentally induced radiocarpal synovitis |
3 |
| Pharmacokinetics and selected pharmacodynamics of morphine and its active metabolites in horses after intravenous administration of four doses |
3 |
| Effects of experimentally induced respiratory disease on the pharmacokinetics and tissue residues of tulathromycin in meat goats |
3 |
| Noninferiority trial investigating the efficacy of a nonantibiotic intramammary therapy in the treatment of mild-to-moderate clinical mastitis in dairy cows with longer lasting udder diseases |
3 |
| Pharmacokinetics of doxycycline after oral administration of single and multiple dose in broiler chickens |
3 |
| Clinical efficiency and safety of Hsp90 inhibitor Novobiocin in avian tibial dyschondroplasia |
3 |
| A double-blind, placebo-controlled, randomized study to evaluate the weight gain drug, mirtazapine transdermal ointment, in cats with unintended weight loss |
3 |
| Pharmacokinetics of single-dose sildenafil administered orally in clinically healthy dogs: Effect of feeding and dose proportionality |
3 |
| Pharmacokinetics of ketorolac in wild Eastern box turtles (Terrapene carolina carolina) after single intramuscular administration |
3 |
| Pharmacokinetics, pharmacodynamics and clinical use of trazodone and its active metabolite m-chlorophenylpiperazine in the horse |
3 |
| Pharmacokinetics and bioavailability of danofloxacin in chukar partridge (Alectoris chukar) following intravenous, intramuscular, subcutaneous, and oral administrations |
3 |
| Assessment of the long-acting ivermectin formulation in sheep: Further insight into potential pharmacokinetic interactions |
3 |
| Pharmacokinetics of a single intramuscular injection of cefquinome in buffalo calves |
3 |
| Pharmacokinetics and tissue distribution of enrofloxacin after single intramuscular injection in Pacific white shrimp |
2 |
| Re-evaluation of the regulation of omeprazole in racehorses: An evidence-based approach |
2 |
| Comparison of milk and plasma pharmacokinetics of meloxicam in postpartum versus mid-lactation Holstein cows |
2 |
| Pharmacokinetics of cefquinome in healthy and Pasteurella multocida-infected rabbits |
2 |
| Effects of the sodium-glucose cotransporter 2 (SGLT2) inhibitor velagliflozin, a new drug with therapeutic potential to treat diabetes in cats |
2 |
| Interactions between erythromycin, flunixin meglumine, levamisole and plant secondary metabolites towards bovine gastrointestinal motilityin vitro study |
2 |
| Tilmicosin- and florfenicol-loaded hydrogenated castor oil-solid lipid nanoparticles to pigs: Combined antibacterial activities and pharmacokinetics |
2 |
| Understanding the effect of repeated administration of meloxicam on feline renal cortex and medulla: A lipidomics and metabolomics approach |
2 |
| Pharmacokinetics of transdermal flunixin in sows |
2 |
| Pharmacokinetic profiles of the two major active metabolites of metamizole (dipyrone) in cats following three different routes of administration |
2 |
| Pharmacodynamic evaluation of the effects of oral melatonin on expression of the T-cell cytokines interleukin-2 and interferon gamma in the dog |
2 |
